Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

CRISM Therapeutics Stock Gains 5.26% as Glioblastoma Drug-Delivery Platform Moves Toward Clinical Testing

CRISM Therapeutics has become increasingly interesting to investors because its development programme is moving toward a critical stage.

Ankur Sharma | 11 August 2026

Renalytix Stock Surges 22.97% as KidneyIntelX Momentum Puts AI-Driven Kidney Diagnostics Back in Focus

Renalytix became a major small-cap healthcare mover on 10 August 2026, with LSE:RENX shares rising22.97%.

Ankur Sharma | 11 August 2026

LSE:MPAL Shares Rise 8% as Record July Trading, Pharmacy Expansion and AI Health Platform Drive Momentum

MedPal AI was among the notable UK healthcare and technology gainers on 10 August 2026, with LSE:MPAL shares rising8.00%.

Ankur Sharma | 11 August 2026

Physiomics Falls 6.92% as Investors Focus on New Oncology Contracts, Biometrics Growth and Operating Leverage

Physiomics has declined6.92% on 10 August 2026, despite several positive commercial developments during recent months.

Ankur Sharma | 10 August 2026

Proteome Sciences Share Price Slides 7.74%: Can Chemoproteomics Turnaround Drive the Next Growth Phase?

Proteome Sciences has fallen7.74% on 10 August 2026, placing LSE:PRM among the weaker UK healthcare and biotechnology shares.

Ankur Sharma | 10 August 2026

Surgical Innovations Shares Fall 10.00% as Investors Weigh 2026 Growth, Margins and Medical Device Demand

Surgical Innovations Group has fallen10.00% on 10 August 2026, bringing renewed attention to the company's growth trajectory, profitability and position within the medical-device market.

Ankur Sharma | 10 August 2026

Why GSK Stock Is in Focus After Strong Specialty Medicines Growth and Upgraded 2026 Outlook

GSK is firmly back on investors' radar after its shares declined2.14% on 10 August 2026.

Ankur Sharma | 10 August 2026

ImmuPharma Stock Drops 9.01%: Why IMM Shares Are Under Pressure as Lupuzor and Kapiglucagon Take Centre Stage

ImmuPharma has fallen9.01% on 10 August 2026, bringing renewed attention to the company's development pipeline and financial position.

Ankur Sharma | 10 August 2026

Is Oxford Nanopore Technologies plc Building on Recent Gains?

Daily Change:+5.10p (up 4.08%) as of the latest session

Ishan Mudgal | 10 August 2026

Is Convatec Group Plc Building on Recent Gains?

Daily Change:-1.70p (down 0.73%) as of the latest session

Ishan Mudgal | 10 August 2026
Support

Hi! How can we help you today?

Loading…